USPTO Says Study Disproves Pharma Patent Thicket Claims

A U.S. Patent and Trademark Office unit has found that pharmaceutical patent thickets are rare after investigating arguments about their effect on drug pricing, the division's leader said Wednesday as part...

Already a subscriber? Click here to view full article